Wegovy was created available in Europe’s most obese nation on Sept. four, in what Novo called a “controlled and limited start”. The Norwegian Medicines Company said in January 2023 it wouldn't subsidise the drug, stating the price can be also large in relation towards the documented health and fitness effects. https://andrewo999fra2.ourabilitywiki.com/user